Literature DB >> 7590658

Inhibition of nitric oxide synthesis in the forearm arterial bed of patients with advanced cirrhosis.

B Campillo1, P E Chabrier, G Pelle, S Sediame, G Atlan, P Fouet, S Adnot.   

Abstract

Increased vascular production of nitric oxide (NO) may contribute to the peripheral vasodilation and hyperdynamic state complicating advanced liver cirrhosis. In this study, we examined the effect on forearm blood flow of local brachial artery infusion of noradrenaline (NA) and NG-monomethyl-L-arginine (L-NMMA), an inhibitor of NO-synthase, in 10 alcoholic ascitic cirrhotic patients (patients with decompensated alcohol-induced liver disease: DALD group) and 10 patients with well-compensated alcohol-induced liver disease (CALD group). Forearm blood flow was measured by venous occlusion plethysmography. As compared with the CALD group, the DALD group had higher cardiac index and forearm blood flow as well as lower systemic blood pressure and vascular resistance. Infusions of NA and L-NMMA produced similar reduction in resting blood flow in the CALD group. However, in the DALD group, NA was significantly less effective than L-NMMA. The forearm vasoconstrictor response to NA was also significantly reduced in the DALD group when compared with the CALD group. In the DALD group, NA decreased forearm blood flow by 21.0 +/- 6.2% and increased vascular resistance by 37.2 +/- 12.3%, whereas respective changes in the CALD group were 41.8 +/- 6.2% (P < .01) and 77.8 +/- 9.9% (P < .02). In contrast, L-NMMA induced greater forearm vasoconstriction in the DALD group than in the CALD group. In decompensated patients, L-NMMA decreased forearm blood flow by 50.4 +/- 2.7% and increased vascular resistance by 115.9 +/- 14.4%, whereas changes in compensated patients were 38.2 +/- 4.9% (P < .05) and 77.4 +/- 16.2% (NS), respectively. These results are consistent with the hypothesis that increased vascular synthesis of NO contributes to the high dynamic state of patients with advanced cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7590658

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Increased EETs participate in peripheral endothelial dysfunction of cirrhosis.

Authors:  David Sacerdoti; Despina Mania; Houli Jiang; Paola Pesce; Silvia Gaiani; Angelo Gatta; Massimo Bolognesi
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-01-10       Impact factor: 3.072

2.  The relationship of heart rate variability with severity and prognosis of cirrhosis.

Authors:  Fehmi Ates; Ergun Topal; Feridun Kosar; Melih Karincaoglu; Bulent Yildirim; Yuksel Aksoy; Murat Aladag; Murat M M Harputluoglu; Ulvi Demirel; Hakan Alan; Fatih Hilmioglu
Journal:  Dig Dis Sci       Date:  2006-08-22       Impact factor: 3.199

3.  Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.

Authors:  P Y Martin; M Ohara; P Gines; D L Xu; J St John; M Niederberger; R W Schrier
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

4.  Evidence for altered vascular responses to exogenous endothelin-1 in patients with advanced cirrhosis with restoration of the normal vasoconstrictor response following successful liver transplantation.

Authors:  R B Vaughan; P W Angus; J P F Chin-Dusting
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 5.  Endothelial and microvascular function in liver cirrhosis: an old concept that needs re-evaluation?

Authors:  Ioanna Papagiouvanni; Pantelis Sarafidis; Marieta P Theodorakopoulou; Emmanouil Sinakos; Ioannis Goulis
Journal:  Ann Gastroenterol       Date:  2022-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.